Apixaban/edoxabanMajor bleeding and gastrointestinal bleeding: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1938卷 / 1期

关键词：

D O I：

10.1007/s40278-023-30361-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：220 / 220

相关论文

共 50 条

[1] Apixaban/rivaroxabanMajor gastrointestinal bleeding: 2 case reports
[J]. Reactions Weekly, 2020, 1791 (1) : 39 - 39
[2] Apixaban/aspirin/ticagrelorLower gastrointestinal bleeding: 2 case reports
[J]. Reactions Weekly, 2021, 1885 (1) : 85 - 85
[3] Apixaban/rivaroxabanCerebrovascular accident and gastrointestinal bleeding: 2 case reports
[J]. Reactions Weekly, 2017, 1677 (1) : 46 - 46
[4] Apixaban/aspirinTraumatic subdural haematoma and gastrointestinal bleeding: 2 case reports
[J]. Reactions Weekly, 2022, 1909 (1) : 88 - 88
[5] Apixaban/rivaroxabanRecurrent gross haematuria and gastrointestinal bleeding: 2 case reports
[J]. Reactions Weekly, 2023, 1965 (1) : 84 - 84
[6] Apixaban/warfarinMinor gastrointestinal bleeding and lack of efficacy: 2 case reports
[J]. Reactions Weekly, 2022, 1899 (1) : 61 - 61
[7] Apixaban/rivaroxaban/warfarinNasal and gastrointestinal bleeding: 3 case reports
[J]. Reactions Weekly, 2020, 1823 (1) : 72 - 72
[8] Apixaban/rivaroxabanMajor bleeding: 2 case reports
[J]. Reactions Weekly, 2018, 1686 (1) : 52 - 52
[9] Apixaban/rivaroxabanIntracranial bleeding: 2 case reports
[J]. Reactions Weekly, 2022, 1935 (1) : 90 - 90
[10] Apixaban/rivaroxabanGastrointestinal bleeding: 2 case reports
[J]. Reactions Weekly, 2017, 1654 (1) : 54 - 54

← 1 2 3 4 5 →